These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


230 related items for PubMed ID: 25135378

  • 1. Analysis of patients with atypical hemolytic uremic syndrome treated at the Mie University Hospital: concentration of C3 p.I1157T mutation.
    Matsumoto T, Fan X, Ishikawa E, Ito M, Amano K, Toyoda H, Komada Y, Ohishi K, Katayama N, Yoshida Y, Matsumoto M, Fujimura Y, Ikejiri M, Wada H, Miyata T.
    Int J Hematol; 2014 Nov; 100(5):437-42. PubMed ID: 25135378
    [Abstract] [Full Text] [Related]

  • 2. [Atypical hemolytic uremic syndrome with C3 p.I1157T missense mutation successfully treated with eculizumab].
    Okano M, Matsumoto T, Nakamori Y, Ino K, Miyazaki K, Fujieda A, Sugimoto Y, Tawara I, Yamaguchi M, Ohishi K, Miwa H, Masuya M, Wada H, Katayama N.
    Rinsho Ketsueki; 2018 Nov; 59(2):178-181. PubMed ID: 29515070
    [Abstract] [Full Text] [Related]

  • 3. Clinical Manifestation of Patients With Atypical Hemolytic Uremic Syndrome With the C3 p.I1157T Variation in the Kinki Region of Japan.
    Matsumoto T, Toyoda H, Amano K, Hirayama M, Ishikawa E, Fujimoto M, Ito M, Ohishi K, Katayama N, Yoshida Y, Matsumoto M, Kawamura N, Ikejiri M, Kawakami K, Miyata T, Wada H.
    Clin Appl Thromb Hemost; 2018 Nov; 24(8):1301-1307. PubMed ID: 29695177
    [Abstract] [Full Text] [Related]

  • 4. A novel quantitative hemolytic assay coupled with restriction fragment length polymorphisms analysis enabled early diagnosis of atypical hemolytic uremic syndrome and identified unique predisposing mutations in Japan.
    Yoshida Y, Miyata T, Matsumoto M, Shirotani-Ikejima H, Uchida Y, Ohyama Y, Kokubo T, Fujimura Y.
    PLoS One; 2015 Nov; 10(5):e0124655. PubMed ID: 25951460
    [Abstract] [Full Text] [Related]

  • 5. Relative role of genetic complement abnormalities in sporadic and familial aHUS and their impact on clinical phenotype.
    Noris M, Caprioli J, Bresin E, Mossali C, Pianetti G, Gamba S, Daina E, Fenili C, Castelletti F, Sorosina A, Piras R, Donadelli R, Maranta R, van der Meer I, Conway EM, Zipfel PF, Goodship TH, Remuzzi G.
    Clin J Am Soc Nephrol; 2010 Oct; 5(10):1844-59. PubMed ID: 20595690
    [Abstract] [Full Text] [Related]

  • 6. Analysis of genetic and predisposing factors in Japanese patients with atypical hemolytic uremic syndrome.
    Fan X, Yoshida Y, Honda S, Matsumoto M, Sawada Y, Hattori M, Hisanaga S, Hiwa R, Nakamura F, Tomomori M, Miyagawa S, Fujimaru R, Yamada H, Sawai T, Ikeda Y, Iwata N, Uemura O, Matsukuma E, Aizawa Y, Harada H, Wada H, Ishikawa E, Ashida A, Nangaku M, Miyata T, Fujimura Y.
    Mol Immunol; 2013 Jun; 54(2):238-46. PubMed ID: 23314101
    [Abstract] [Full Text] [Related]

  • 7. Disease Recurrence After Early Discontinuation of Eculizumab in a Patient With Atypical Hemolytic Uremic Syndrome With Complement C3 I1157T Mutation.
    Toyoda H, Wada H, Miyata T, Amano K, Kihira K, Iwamoto S, Hirayama M, Komada Y.
    J Pediatr Hematol Oncol; 2016 Apr; 38(3):e137-9. PubMed ID: 26840081
    [Abstract] [Full Text] [Related]

  • 8. Genetic analysis and functional characterization of novel mutations in a series of patients with atypical hemolytic uremic syndrome.
    Szarvas N, Szilágyi Á, Csuka D, Takács B, Rusai K, Müller T, Arbeiter K, Réti M, Haris Á, Wagner L, Török S, Kelen K, Szabó AJ, Reusz GS, Morgan BP, Prohászka Z.
    Mol Immunol; 2016 Mar; 71():10-22. PubMed ID: 26826462
    [Abstract] [Full Text] [Related]

  • 9. aHUS associated with C3 gene mutation: a case with numerous relapses and favorable 20-year outcome.
    Siomou E, Gkoutsias A, Serbis A, Kollios K, Chaliasos N, Frémeaux-Bacchi V.
    Pediatr Nephrol; 2016 Mar; 31(3):513-7. PubMed ID: 26572892
    [Abstract] [Full Text] [Related]

  • 10. The molecular and structural bases for the association of complement C3 mutations with atypical hemolytic uremic syndrome.
    Martínez-Barricarte R, Heurich M, López-Perrote A, Tortajada A, Pinto S, López-Trascasa M, Sánchez-Corral P, Morgan BP, Llorca O, Harris CL, Rodríguez de Córdoba S.
    Mol Immunol; 2015 Aug; 66(2):263-73. PubMed ID: 25879158
    [Abstract] [Full Text] [Related]

  • 11. Novel C3 mutation p.Lys65Gln in aHUS affects complement factor H binding.
    Volokhina E, Westra D, Xue X, Gros P, van de Kar N, van den Heuvel L.
    Pediatr Nephrol; 2012 Sep; 27(9):1519-24. PubMed ID: 22669319
    [Abstract] [Full Text] [Related]

  • 12. Statistical Validation of Rare Complement Variants Provides Insights into the Molecular Basis of Atypical Hemolytic Uremic Syndrome and C3 Glomerulopathy.
    Osborne AJ, Breno M, Borsa NG, Bu F, Frémeaux-Bacchi V, Gale DP, van den Heuvel LP, Kavanagh D, Noris M, Pinto S, Rallapalli PM, Remuzzi G, Rodríguez de Cordoba S, Ruiz A, Smith RJH, Vieira-Martins P, Volokhina E, Wilson V, Goodship THJ, Perkins SJ.
    J Immunol; 2018 Apr 01; 200(7):2464-2478. PubMed ID: 29500241
    [Abstract] [Full Text] [Related]

  • 13. [Atypical hemolytic-uremic syndrome related to abnormalities within the complement system].
    Frémeaux-Bacchi V, Fakhouri F, Roumenina L, Dragon-Durey MA, Loirat C.
    Rev Med Interne; 2011 Apr 01; 32(4):232-40. PubMed ID: 21376430
    [Abstract] [Full Text] [Related]

  • 14. Clinical characteristics and genetic backgrounds of Japanese patients with atypical hemolytic uremic syndrome.
    Fujisawa M, Kato H, Yoshida Y, Usui T, Takata M, Fujimoto M, Wada H, Uchida Y, Kokame K, Matsumoto M, Fujimura Y, Miyata T, Nangaku M.
    Clin Exp Nephrol; 2018 Oct 01; 22(5):1088-1099. PubMed ID: 29511899
    [Abstract] [Full Text] [Related]

  • 15. Genetics and outcome of atypical hemolytic-uremic syndrome in Turkish children: a retrospective study between 2010 and 2017, a single-center experience.
    Conkar S, Mir S, Berdeli A.
    Iran J Kidney Dis; 2019 Sep 01; 13(5):316-321. PubMed ID: 31705748
    [Abstract] [Full Text] [Related]

  • 16. Combined complement gene mutations in atypical hemolytic uremic syndrome influence clinical phenotype.
    Bresin E, Rurali E, Caprioli J, Sanchez-Corral P, Fremeaux-Bacchi V, Rodriguez de Cordoba S, Pinto S, Goodship TH, Alberti M, Ribes D, Valoti E, Remuzzi G, Noris M, European Working Party on Complement Genetics in Renal Diseases.
    J Am Soc Nephrol; 2013 Feb 01; 24(3):475-86. PubMed ID: 23431077
    [Abstract] [Full Text] [Related]

  • 17. Living Donor Kidney Transplantation in Atypical Hemolytic Uremic Syndrome: A Case Series.
    Duineveld C, Verhave JC, Berger SP, van de Kar NCAJ, Wetzels JFM.
    Am J Kidney Dis; 2017 Dec 01; 70(6):770-777. PubMed ID: 28821363
    [Abstract] [Full Text] [Related]

  • 18. Atypical hemolytic uremic syndrome with C3 mutation: A case report and literature review.
    Liu J, Xiao J, Chen L, Peng Y.
    Clin Nephrol; 2021 Mar 01; 95(3):156-160. PubMed ID: 33210998
    [Abstract] [Full Text] [Related]

  • 19. Genetics of atypical hemolytic uremic syndrome (aHUS).
    Rodríguez de Córdoba S, Hidalgo MS, Pinto S, Tortajada A.
    Semin Thromb Hemost; 2014 Jun 01; 40(4):422-30. PubMed ID: 24799305
    [Abstract] [Full Text] [Related]

  • 20. A Novel Homozygous In-Frame Deletion in Complement Factor 3 Underlies Early-Onset Autosomal Recessive Atypical Hemolytic Uremic Syndrome - Case Report.
    Pollack S, Eisenstein I, Mory A, Paperna T, Ofir A, Baris-Feldman H, Weiss K, Veszeli N, Csuka D, Shemer R, Glaser F, Prohászka Z, Magen D.
    Front Immunol; 2021 Jun 01; 12():608604. PubMed ID: 34248927
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 12.